$KNW
KNOW LABS, INC. Stock $knw

$knw Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000165495422016732 Filed on December 20, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2022
Revenue	$0.00		$4.360M
YoY Change	-100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.905M		$8.118M
YoY Change	56.55%		25.35%
% of Gross Profit
Research & Development	$1.743M		$5.386M
YoY Change	96.79%		35.66%
% of Gross Profit
Depreciation & Amortization	$103.2K		$321.0K
YoY Change	147.55%		59.85%
% of Gross Profit
Operating Expenses	$3.648M		$16.93M
YoY Change	16.99%		62.11%
Operating Profit	-$3.648M		-$12.57M
YoY Change	319.49%		20.37%
Interest Expense	$227.2K		$8.019M
YoY Change	-94.94%		-46.23%
% of Operating Profit
Other Income/Expense, Net	-$174.7K		-$7.497M
YoY Change	-96.11%		-49.73%
Pretax Income	-$3.823M		-$20.07M
YoY Change	-28.63%		-20.86%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$3.823M		-$20.07M
YoY Change	-28.63%		-20.86%
Net Earnings / Revenue			-460.34%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.08		-$0.50
COMMON SHARES
Basic Shares Outstanding	48.16M shares	43.85M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022 Q3	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.680M		$12.59M
YoY Change	-9.81%		2.74%
Cash & Equivalents	$9.680M	$12.59M	$12.59M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$9.680M	$12.59M	$12.59M
YoY Change	-30.15%	2.74%	2.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$770.7K	$863.0K	$1.151M
YoY Change	14.63%	162.7%	86.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$15.77K		$13.77K
YoY Change	14.52%		0.0%
Total Long-Term Assets	$1.030M	$1.165M	$1.165M
YoY Change	0.33%	84.5%	84.5%
TOTAL ASSETS
Total Short-Term Assets	$9.680M	$12.59M	$12.59M
Total Long-Term Assets	$1.030M	$1.165M	$1.165M
Total Assets	$10.71M	$13.76M	$13.76M
YoY Change	-28.05%	6.74%	6.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$404.6K		$527.0K
YoY Change	-0.95%		25.74%
Accrued Expenses	$464.8K	$462.9K	$1.027M
YoY Change	-69.18%	-48.17%	-28.06%
Deferred Revenue
YoY Change
Short-Term Debt	$2.255M		$2.255M
YoY Change	-83.14%		-75.46%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.658M	$3.809M	$3.809M
YoY Change	-79.0%	-65.49%	-65.49%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00		$0.00
YoY Change	-100.0%		-100.0%
Other Long-Term Liabilities	$45.99K		$87.12K
YoY Change	-73.2%		-51.1%
Total Long-Term Liabilities	$45.99K	$87.12K	$87.12K
YoY Change	-92.38%	-85.72%	-85.72%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.658M	$3.809M	$3.809M
Total Long-Term Liabilities	$45.99K	$87.12K	$87.12K
Total Liabilities	$3.704M	$3.896M	$3.896M
YoY Change	-79.45%	-66.55%	-66.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$105.2M	-$101.4M
YoY Change	21.39%	24.68%
Common Stock	$48.21K	$48.16K
YoY Change	34.02%	36.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.006M	$9.863M	$9.863M
YoY Change
Total Liabilities & Shareholders Equity	$10.71M	$13.76M	$13.76M
YoY Change	-28.05%	6.74%	6.74%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$3.823M	-$20.07M
YoY Change	-28.63%	-20.86%
Depreciation, Depletion And Amortization	$103.2K	$321.0K
YoY Change	147.55%	59.85%
Cash From Operating Activities	-$2.917M	-$6.920M
YoY Change	52.92%	1.01%
INVESTING ACTIVITIES
Capital Expenditures	$10.85K	$855.5K
YoY Change	-102.81%	-385.6%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$10.85K	-$855.5K
YoY Change	-97.19%	185.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$14.84K	$8.111M
YoY Change	-98.07%	-46.32%
NET CHANGE
Cash From Operating Activities	-$2.917M	-$6.920M
Cash From Investing Activities	-$10.85K	-$855.5K
Cash From Financing Activities	$14.84K	$8.111M
Net Change In Cash	-$2.913M	$335.5K
YoY Change	91.11%	-95.79%
FREE CASH FLOW
Cash From Operating Activities	-$2.917M	-$6.920M
Capital Expenditures	$10.85K	$855.5K
Free Cash Flow	-$2.928M	-$7.775M
YoY Change	92.35%	18.69%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	419093	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	893137	usd
CY2021Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	421599	usd
CY2021Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	9191155	usd
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	112371	usd
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	11037355	usd
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	178170	usd
CY2021Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	609973	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	48158	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	111209388	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13758366	usd
CY2022Q3	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	0	usd
CY2021Q3	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	431803	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87118	usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001074828
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48156062	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35166551	shares
CY2022Q3	knwn	Net Working Capital NetWorkingCapital	11040123	usd
CY2022	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Unearned ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUnearned	11550745	shares
CY2022Q1	us-gaap	Stock Repurchase Program Expiration Date StockRepurchaseProgramExpirationDate	2027-01-05
CY2022Q1	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	838487	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33719669	shares
CY2022	knwn	Proceeds From Issuance Of Common Stocks ProceedsFromIssuanceOfCommonStocks	153000	usd
CY2021	knwn	Proceeds From Issuance Of Common Stocks ProceedsFromIssuanceOfCommonStocks	202820	usd
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33719669	shares
CY2020Q3	knwn	Share Outstanding At Begin Of Period ShareOutstandingAtBeginOfPeriod	23964905	shares
CY2019Q1	knwn	Lease Description LeaseDescription	The lease expires on June 30, 2024
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-37479
CY2022	dei	Entity Registrant Name EntityRegistrantName	KNOW LABS, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0273142
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 Union Street
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 810
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Seattle
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98101
CY2022	dei	City Area Code CityAreaCode	206
CY2022	dei	Local Phone Number LocalPhoneNumber	903-1351
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2022	dei	Trading Symbol TradingSymbol	KNW
CY2022	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Entity Public Float EntityPublicFloat	70531213	usd
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	48157937	shares
CY2022	dei	Auditor Firm AuditorFirmId	207
CY2022	dei	Auditor Name AuditorName	BPM LLP
CY2022	dei	Auditor Location AuditorLocation	Walnut Creek, California
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12593692	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12258218	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	348264	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	87118	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48156062	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35166551	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	35168	usd
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	82530684	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-101397738	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-81326494	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9862613	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1242163	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12889491	usd
CY2022	us-gaap	Revenues Revenues	4360087	usd
CY2021	us-gaap	Revenues Revenues	0	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5385586	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3969972	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8118137	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6476176	usd
CY2022	us-gaap	Selling Expense SellingExpense	3430438	usd
CY2021	us-gaap	Selling Expense SellingExpense	0	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	16934161	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	10446148	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-12574074	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-10446148	usd
CY2022	us-gaap	Interest Expense InterestExpense	8018798	usd
CY2021	us-gaap	Interest Expense InterestExpense	14914065	usd
CY2022	us-gaap	Other Income OtherIncome	521628	usd
CY2021	us-gaap	Other Income OtherIncome	0	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7497170	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-14914065	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20071244	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25360213	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-20071244	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-25360213	usd
CY2022	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.50
CY2021	knwn	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.86
CY2022	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	40370473	shares
CY2021	knwn	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	29370596	shares
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-1914911	usd
CY2021	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	1028522	usd
CY2021	knwn	Conversion Of Debt Offering And Accrued Interest Note7 Amount ConversionOfDebtOfferingAndAccruedInterestNote7Amount	6098058	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	9769683	usd
CY2021	knwn	Issuance Of Warrants To Debt Holders Note7 IssuanceOfWarrantsToDebtHoldersNote7	4439317	usd
CY2021	knwn	Issuance Of Warrants For Services Related To Debt Offering IssuanceOfWarrantsForServicesRelatedToDebtOffering	1667281	usd
CY2021	knwn	Issuance Of Common Stock For Services Amount IssuanceOfCommonStockForServicesAmount	202820	usd
CY2021	knwn	Issuance Of Common Stock Warrant For Services IssuanceOfCommonStockWarrantForServices	2547436	usd
CY2021	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	1313203	usd
CY2021	knwn	Issuance Of Common Stock For Stock Option Exercises Amount IssuanceOfCommonStockForStockOptionExercisesAmount	23344	usd
CY2021	knwn	Issuance Of Shares And Warrants For Conversion Of Simple Agreements For Future Equity Amount IssuanceOfSharesAndWarrantsForConversionOfSimpleAgreementsForFutureEquityAmount	1427622	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-25360213	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	1242163	usd
CY2022	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	4421634	usd
CY2022	knwn	Conversion Of Debt Offering And Accrued Interest Note7 Amount ConversionOfDebtOfferingAndAccruedInterestNote7Amount	15345720	usd
CY2022	knwn	Issuance Of Common Stock For Stock Option Exercises Amount IssuanceOfCommonStockForStockOptionExercisesAmount	26687	usd
CY2022	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	838487	usd
CY2022	knwn	Issuance Of Common Stock For Services Amount IssuanceOfCommonStockForServicesAmount	183000	usd
CY2022	knwn	Issuance Of Common Stock Warrant For Services IssuanceOfCommonStockWarrantForServices	451487	usd
CY2022	knwn	Isssuance Of Common Stock For Nyse Uplisting Amount IsssuanceOfCommonStockForNyseUplistingAmount	7424679	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-20071244	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9862613	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-20071244	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-25360213	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	320995	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	200807	usd
CY2022	knwn	Issuance Of Common Stock For Services IssuanceOfCommonStockForServices	183000	usd
CY2021	knwn	Issuance Of Common Stock For Services IssuanceOfCommonStockForServices	202820	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	451487	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2547436	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	268872	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	-4421634	usd
CY2021	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	-1028522	usd
CY2022	knwn	Right Of Use Net RightOfUseNet	13046	usd
CY2021	knwn	Right Of Use Net RightOfUseNet	-1493	usd
CY2022	knwn	Gain On Forgiveness Of Notes Payable Ppp Loans GainOnForgivenessOfNotesPayablePppLoans	252700	usd
CY2021	knwn	Gain On Forgiveness Of Notes Payable Ppp Loans GainOnForgivenessOfNotesPayablePppLoans	0	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7272911	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	13722672	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-11413	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1009935	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	797337	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6919808	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6850699	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	855468	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	299525	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-855468	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-299525	usd
CY2022	knwn	Proceeds From Isssuance Of Common Stock For Nyse Uplisting ProceedsFromIsssuanceOfCommonStockForNyseUplisting	8280000	usd
CY2021	knwn	Proceeds From Isssuance Of Common Stock For Nyse Uplisting ProceedsFromIsssuanceOfCommonStockForNyseUplisting	0	usd
CY2022	knwn	Payments For Stock Issuance Costs For Nyse Uplisting PaymentsForStockIssuanceCostsForNyseUplisting	855321	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	14209000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	727117	usd
CY2022	knwn	Proceeds From Simple Agreements For Future Equity ProceedsFromSimpleAgreementsForFutureEquity	0	usd
CY2021	knwn	Proceeds From Simple Agreements For Future Equity ProceedsFromSimpleAgreementsForFutureEquity	340000	usd
CY2022	knwn	Repayments On Simple Agreements For Future Equity RepaymentsOnSimpleAgreementsForFutureEquity	0	usd
CY2021	knwn	Repayments On Simple Agreements For Future Equity RepaymentsOnSimpleAgreementsForFutureEquity	253800	usd
CY2022	knwn	Proceeds From Note Payableppp ProceedsFromNotePayableppp	0	usd
CY2021	knwn	Proceeds From Note Payableppp ProceedsFromNotePayableppp	205633	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	179103	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	26687	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	23344	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	838487	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1313203	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8110750	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15110263	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	335474	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	7960039	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12258218	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4298179	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12593692	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12258218	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	18800	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	0	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	9769683	usd
CY2022	knwn	Issuance Of Warrants To Debt Holders IssuanceOfWarrantsToDebtHolders	0	usd
CY2021	knwn	Issuance Of Warrants To Debt Holders IssuanceOfWarrantsToDebtHolders	4439317	usd
CY2022	knwn	Issuance Of Warrants For Services Related To Debt Offering IssuanceOfWarrantsForServicesRelatedToDebtOffering	0	usd
CY2021	knwn	Issuance Of Warrants For Services Related To Debt Offering IssuanceOfWarrantsForServicesRelatedToDebtOffering	1667281	usd
CY2022	knwn	Cashless Warrant Exercise CashlessWarrantExercise	0	usd
CY2021	knwn	Cashless Warrant Exercise CashlessWarrantExercise	515975	usd
CY2022	knwn	Conversion Of Debt Offering ConversionOfDebtOffering	14209000	usd
CY2021	knwn	Conversion Of Debt Offering ConversionOfDebtOffering	5638275	usd
CY2022	knwn	Conversion Of Accrued Interest ConversionOfAccruedInterest	1136720	usd
CY2021	knwn	Conversion Of Accrued Interest ConversionOfAccruedInterest	460185	usd
CY2022	knwn	Issuance Of Shares And Warrants For Conversion Of Simple Agreements For Future Equity IssuanceOfSharesAndWarrantsForConversionOfSimpleAgreementsForFutureEquity	0	usd
CY2021	knwn	Issuance Of Shares And Warrants For Conversion Of Simple Agreements For Future Equity IssuanceOfSharesAndWarrantsForConversionOfSimpleAgreementsForFutureEquity	1427141	usd
CY2022Q3	knwn	Authorized Shares Of Capital Stock AuthorizedSharesOfCapitalStock	205000000	shares
CY2022Q3	knwn	Authorized Shares Of Capital Common Stock AuthorizedSharesOfCapitalCommonStock	200000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	knwn	Authorized Common Stock Increased AuthorizedCommonStockIncreased	200000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Proceeds From Sale Of Other Assets1 ProceedsFromSaleOfOtherAssets1	4360087	usd
CY2021	knwn	Segment Revenues SegmentRevenues	0	usd
CY2021	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-10446000	usd
CY2021Q3	knwn	Segment Assets SegmentAssets	12889000	usd
CY2022Q3	knwn	Cash And Cash Equivalents CashAndCashEquivalents	12593692	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-101397738	usd
CY2022	knwn	Proceeds Of Warrants Currently Outstanding ProceedsOfWarrantsCurrentlyOutstanding	7424679	usd
CY2022Q3	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	250000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	610956	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	329375	usd
CY2022Q3	knwn	Debt Discount Warrants Issued For Services DebtDiscountWarrantsIssuedForServices	0	usd
CY2021Q3	knwn	Debt Discount Warrants Issued For Services DebtDiscountWarrantsIssuedForServices	-1056984	usd
CY2022	knwn	Description Of Automatic Conversion Of Convertible DescriptionOfAutomaticConversionOfConvertible	The Company issued 7,672,860 shares of common stock related to the automatic conversion of convertible notes and interest from a private placement to accredited investors in 2021. The convertible notes and interest were automatically converted to common stock at $2.00 per share on the one-year anniversary in March 2022.
CY2022	knwn	Shrare Issued Warrant To Purchased Price ShrareIssuedWarrantToPurchasedPrice	1.749
CY2022	us-gaap	Revenue Recognition Leases RevenueRecognitionLeases	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Revenue Recognition</em></strong><strong> </strong>– The Company determines revenue recognition from contracts with customers through the following steps:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">identification of the contract, or contracts, with the customer;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">identification of the performance obligations in the contract;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">determination of the transaction price;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">allocation of the transaction price to the performance obligations in the contract; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;">recognition of the revenue when, or as, the Company satisfies a performance obligation.</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Revenue is recognized when control of the promised goods or services is transferred to the customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. During the year ended September 30, 2022, the Company’s artificial AI deep learning platform began generating revenue from digital asset sales of NFT’s. The Company engineering team, using its research data, AI and proprietary algorithms, produced NFT’s in the form of digital art. The NFT’s produced had no recorded cost basis. </p>
CY2022	knwn	Earns Royalty EarnsRoyalty	0.10	pure
CY2022	knwn	Total Amount Of Digital Asset Conversion Losses TotalAmountOfDigitalAssetConversionLosses	3430438	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5385586	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3969972	usd
CY2022Q3	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	11821931	usd
CY2021Q3	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	12217714	usd
CY2022	us-gaap	Derivatives Methods Of Accounting Hedge Effectiveness DerivativesMethodsOfAccountingHedgeEffectiveness	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Derivative Financial Instruments</em></strong><strong> – </strong>Pursuant to ASC 815 “Derivatives and Hedging”, the Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company then determines if embedded derivative must be bifurcated and separately accounted for. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determined that the conversion features for purposes of bifurcation within its currently outstanding convertible notes payable were immaterial and there was no derivative liability to be recorded as of September 30, 2022 and 2021.</p>
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48156062	shares
CY2022Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	2255066	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35166551	shares
CY2021	knwn	Additional Common Shares Reserved AdditionalCommonSharesReserved	16124764	shares
CY2021Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	16464066	shares
CY2021Q3	knwn	Debt Discount Warrants DebtDiscountWarrants	-1957590	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Use of Estimates</em></strong> – The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2021	knwn	Description Of Automatic Conversion Of Convertible DescriptionOfAutomaticConversionOfConvertible	The Company issued 6,091,960 shares of common stock related to the automatic conversion of convertible notes and interest from a private placement to accredited investors in 2020. The convertible notes and interested were automatically converted to common stock at $1.00 per share on the one-year anniversary starting on October 17, 2020.
CY2022	knwn	Artificial Intelligence Ai Deep Learning Platform ArtificialIntelligenceAiDeepLearningPlatform	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>4. AI DEEP LEARNING PLATFORM</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the year ended September 30, 2022, the Company’s AI deep learning platform began generating revenue from digital asset sales of NFT’s and had sales of $4,360,087. The Company’s sales of NFT’s are generated using the NFT digital exchange, OpenSea. Customers purchasing the NFT’s must make payments in the crypto currency, Ethereum. The Ethereum is received into a digital wallet and then moved to an account at Coinbase where the Ethereum is converted to U.S. dollars. During the three months ended December 31, 2021, the Company was not able to establish a digital wallet and corporate account at Coinbase in order to receive the Ethereum. The Company used the digital wallet and Coinbase account of the Company’s CEO. The Company and the CEO executed an assignment of his account to the Company while the Company establishes its own Coinbase account. All proceeds received from the sale of NFT were deposited in the CEO’s personal digital accounts.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">After the sale of the NFT, the Ethereum is converted to US dollars as soon as practically possible. The Company records the total value of the gross NFT sale in revenue. Costs incurred in connection with the NFT transaction are recorded in the statement of operations as selling and transactional cost of digital assets and include costs to outside consultants, estimated employee and CEO special bonus compensation, digital asset conversion losses and estimated sales and use tax. The amount totaled $3,430,438 for the year ended September 30, 2022. As of September 30, 2022, accrued expenses include $343,878 of expenses, primarily sales and use tax and other expenses.</p>
CY2022Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1510265	usd
CY2021Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	654798	usd
CY2022Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3612	usd
CY2021Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3612	usd
CY2022Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	26855	usd
CY2021Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	26855	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	677755	usd
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	356761	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	862977	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	328504	usd
CY2022	us-gaap	Depreciation Depreciation	320995	usd
CY2021	us-gaap	Depreciation Depreciation	99693	usd
CY2022Q3	knwn	Right Of Use Assets RightOfUseAssets	302000	usd
CY2022Q3	knwn	Total Lease Liability TotalLeaseLiability	302000	usd
CY2021Q3	knwn	Total Lease Liability TotalLeaseLiability	291000	usd
CY2022	us-gaap	Lease Cost LeaseCost	289018	usd
CY2021	us-gaap	Lease Cost LeaseCost	139643	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	292363	usd
CY2022	knwn	Weighted Average Remaining Lease Term WeightedAverageRemainingLeaseTerm	P17Y
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07	pure
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	194537	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	127232	usd
CY2022Q3	knwn	Total Remaining Payments TotalRemainingPayments	321769	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	19254	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	302515	usd
CY2022Q3	knwn	Convertible Notes Conversions ConvertibleNotesConversions	-14209000	usd
CY2021Q3	knwn	Convertible Notes Conversions ConvertibleNotesConversions	-5639500	usd
CY2022Q3	knwn	Debt Discount Beneficial Conversion Feature DebtDiscountBeneficialConversionFeature	0	usd
CY2021Q3	knwn	Debt Discount Beneficial Conversion Feature DebtDiscountBeneficialConversionFeature	-4308337	usd
CY2022Q3	knwn	Debt Discount Warrants DebtDiscountWarrants	0	usd
CY2022Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2255066	usd
CY2021Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	9191155	usd
CY2022	knwn	Gain On Loan Forgiveness GainOnLoanForgiveness	253000	usd
CY2022Q4	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	2250	usd
CY2022Q4	knwn	Lease Description LeaseDescription	The lease expires November 22, 2023
CY2021	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	838487	shares
CY2021Q3	knwn	Convertible Notes Payable4 D ConvertibleNotesPayable4D	7104500	usd
CY2021Q3	knwn	No Of Share Exercisable Common Stock NoOfShareExercisableCommonStock	3552250	shares
CY2022Q3	knwn	Warrant Issued To Common Stock WarrantIssuedToCommonStock	384359	shares
CY2022	knwn	Forfeited Per Share Exercise ForfeitedPerShareExercise	1.155
CY2022	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	43254	shares
CY2022	knwn	Forfeited Per Share ForfeitedPerShare	1.155
CY2021Q3	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbers ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbers	22564255	shares
CY2021Q3	knwn	Outstanding At Begenning Of Period OutstandingAtBegenningOfPeriod	0.998
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	389800	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.271
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1045724	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.835
CY2022	knwn	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	122018	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.918
CY2022	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbe ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbe	21786313	shares
CY2022Q3	knwn	Outstanding At End Of Period OutstandingAtEndOfPeriod	1.029
CY2022Q3	knwn	Exercisable At End Of Period ExercisableAtEndOfPeriod	21786313	shares
CY2022	srt	Federal Funds Sold Average Yield FederalFundsSoldAverageYield	0	pure
CY2022	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P3Y
CY2022	knwn	Expected Life Maximum ExpectedLifeMaximum	P5Y
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	1.04	pure
CY2022	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.0296	pure
CY2022	knwn	Sharebased Compensation Arrangements By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementsBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	21786313	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	24047814	usd
CY2022Q3	knwn	Warrant Issued To Common Stocks WarrantIssuedToCommonStocks	26293	shares
CY2022	knwn	Exercise Stock Option Grants ExerciseStockOptionGrants	26887	shares
CY2021	knwn	Stock Option Grants Total StockOptionGrantsTotal	9145745	shares
CY2021	knwn	Stock Option Grants Vest StockOptionGrantsVest	1505000	shares
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P4Y
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	716618	usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	5121290	usd
CY2021	us-gaap	Other Noncash Expense OtherNoncashExpense	3978092	usd
CY2020Q3	knwn	Share Based Compensation Arrangement By Share Based Payment Awards Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsOutstandingWeightedAverageExercisePrice	1.161
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5580550	usd
CY2021	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsGrantsInPeriodWeightedAverageExercisePrice	1.766
CY2021	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted	18807990	usd
CY2021	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsExercisesInPeriodWeightedAverageExercisePrice	-1.359
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	28031	usd
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.300
CY2021	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueForfeitures	-396000	usd
CY2021Q3	knwn	Share Based Compensation Arrangement By Share Based Payment Awards Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardsOptionsOutstandingWeightedAverageExercisePrice	1.565
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23964509	usd
CY2022	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsGrantsInPeriodWeightedAverageExercisePrice	1.815
CY2022	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueGranted	12045330	usd
CY2022	knwn	Share Based Compensation Arrangements By Share Based Payment Awards Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardsOptionsExercisesInPeriodWeightedAverageExercisePrice	-1.376
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	36170	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.057
CY2022	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueForfeitures	-2329267	usd
CY2021Q3	knwn	Share Outstanding At Begin Of Period ShareOutstandingAtBeginOfPeriod	33644402	shares
CY2022	knwn	Intrinsic Value IntrinsicValue	14265304	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	4421634	usd
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1028522	usd
CY2022Q3	knwn	Unrecognized Compensation Costs UnrecognizedCompensationCosts	8850989	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y11M4D
CY2017Q2	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	3334	usd
CY2017Q2	knwn	Lease Description LeaseDescription	lease expired on May 31, 2022
CY2021Q2	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	2986	usd
CY2019Q1	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	8697	usd
CY2021Q2	knwn	Lease Description LeaseDescription	increases by 3% annually. The lease expires on June 30, 2024. The lease can be extended for one additional three year term.
CY2021Q4	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	5000	usd
CY2022Q3	us-gaap	Sale Leaseback Transaction Monthly Rental Payments SaleLeasebackTransactionMonthlyRentalPayments	7000	usd
CY2022Q3	knwn	Lease Description LeaseDescription	The lease expires September 30, 2023 and can be extended on a month to month basis.
CY2022Q3	us-gaap	Payments For Rent PaymentsForRent	91500	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	9372000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	8051000	usd
CY2022Q3	knwn	Stock Based Compensation StockBasedCompensation	1677000	usd
CY2021Q3	knwn	Stock Based Compensation StockBasedCompensation	975000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	221000	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	276000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	97000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	399000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11367000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9701000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11367000	usd
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9701000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1666000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1092357	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.09	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.12	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.08	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.07	pure
CY2022	knwn	Prior Year True Up PriorYearTrueUp	0.04	pure
CY2021	knwn	Prior Year True Up PriorYearTrueUp	0.02	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	knwn	Segment Revenues SegmentRevenues	4360000	usd
CY2022	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-12574000	usd
CY2022Q3	knwn	Segment Assets SegmentAssets	13758000	usd

Files In Submission

Name	View Source	Status
0001654954-22-016732-index-headers.html	Edgar Link	pending
0001654954-22-016732-index.html	Edgar Link	pending
0001654954-22-016732.txt	Edgar Link	pending
0001654954-22-016732-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
knwn-20220930.xsd	Edgar Link	pending
knwn_10k.htm	Edgar Link	pending
knwn_ex1030.htm	Edgar Link	pending
knwn_ex1031.htm	Edgar Link	pending
knwn_ex311.htm	Edgar Link	pending
knwn_ex312.htm	Edgar Link	pending
knwn_ex321.htm	Edgar Link	pending
knwn_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
knwn-20220930_def.xml	Edgar Link	unprocessable
knwn-20220930_lab.xml	Edgar Link	unprocessable
knwn-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
knwn-20220930_cal.xml	Edgar Link	unprocessable
knwn_10k_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KNW
KNOW LABS, INC. Stock $knw

2022 Q4 Form 10-K Financial Statement

#000165495422016732 Filed on December 20, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW KNOW LABS, INC. Stock $knw

2022 Q4 Form 10-K Financial Statement

#000165495422016732 Filed on December 20, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW
KNOW LABS, INC. Stock $knw